dronedarone has been researched along with Torsade de Pointes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Chiba, K; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Lubna, NJ; Motokawa, Y; Naito, AT; Nakamura, Y; Sugiyama, A; Yamazaki, H | 1 |
| Bronder, E; Garbe, E; Haverkamp, W; Huemer, M; Klimpel, A; Sarganas, G | 1 |
| Breithardt, G; Eckardt, L; Frommeyer, G; Kaiser, D; Milberg, P; Osada, N; Uphaus, T | 1 |
| Hiatt, WR; Kao, DP; Krantz, MJ | 1 |
| Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C | 1 |
| Leunissen, HD; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ | 1 |
| de Groot, SH; Leunissen, JD; Molenschot, MM; Schoenmakers, M; van Der Hulst, FF; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ | 1 |
1 review(s) available for dronedarone and Torsade de Pointes
| Article | Year |
|---|---|
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modality Therapy; Defibrillators, Implantable; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazolidines; Ion Transport; Life Tables; Membrane Potentials; Meta-Analysis as Topic; Phenethylamines; Piperazines; Risk Assessment; Sotalol; Sulfonamides; Survival Analysis; Torsades de Pointes; Treatment Outcome | 2004 |
6 other study(ies) available for dronedarone and Torsade de Pointes
| Article | Year |
|---|---|
In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Output; Disease Models, Animal; Dogs; Dronedarone; Electrocardiography; Heart Conduction System; Heart Rate; Male; Refractory Period, Electrophysiological; Risk Assessment; Time Factors; Torsades de Pointes; Ventricular Function, Left; Ventricular Pressure | 2018 |
Torsade de pointes tachycardia in a patient on dronedarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Female; Humans; Torsades de Pointes | 2015 |
Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dronedarone; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Ventricles; In Vitro Techniques; Long QT Syndrome; Perfusion; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Function | 2012 |
Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dronedarone; Heart Arrest; Humans; Retrospective Studies; Torsades de Pointes; United States; United States Food and Drug Administration | 2012 |
Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Dogs; Dronedarone; Electrocardiography; Female; Heart Ventricles; Injections, Intravenous; Male; Propanolamines; Time Factors; Torsades de Pointes; Ventricular Function | 1999 |
Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Catheterization; Disease Models, Animal; Dogs; Dronedarone; Electrocardiography; Electrophysiologic Techniques, Cardiac; Epinephrine; Female; Heart Block; Hemodynamics; Long QT Syndrome; Male; Myocardium; Organ Size; Torsades de Pointes; Vasoconstrictor Agents; Wakefulness | 2001 |